PROMETIC TO DEVELOP AND COMMERCIALIZE ALPHA1-ANTITRYPSIN AS SECOND PLASMA-DERIVED ORPHAN DRUG PRODUCT

August 14, 2013
Posted by: Prometic Prometic
Posted In: Press Releases, Press Releases 2013
X